These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 23110398

  • 1. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.
    Lohr V, Genzel Y, Jordan I, Katinger D, Mahr S, Sandig V, Reichl U.
    BMC Biotechnol; 2012 Oct 30; 12():79. PubMed ID: 23110398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M, Farooq M, Dang T, Cortes B, Liu J, Maranga L.
    Biotechnol Bioeng; 2010 Aug 15; 106(6):906-17. PubMed ID: 20589670
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    Tapia F, Wohlfarth D, Sandig V, Jordan I, Genzel Y, Reichl U.
    PLoS One; 2019 Aug 15; 14(11):e0224317. PubMed ID: 31689309
    [Abstract] [Full Text] [Related]

  • 7. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D, Jordan I, Sandig V, Genzel Y, Reichl U.
    Appl Microbiol Biotechnol; 2019 Apr 15; 103(7):3025-3035. PubMed ID: 30796494
    [Abstract] [Full Text] [Related]

  • 8. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.
    Trabelsi K, Zakour MB, Jordan I, Sandig V, Rourou S, Kallel H.
    BMC Biotechnol; 2022 Jun 17; 22(1):17. PubMed ID: 35715843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
    Peschel B, Frentzel S, Laske T, Genzel Y, Reichl U.
    Vaccine; 2013 Nov 19; 31(48):5693-9. PubMed ID: 24113260
    [Abstract] [Full Text] [Related]

  • 11. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Rekstin A, Donina S, Pisareva M, Grigorieva E, Kryshen K, Muzhikyan A, Makarova M, Sparrow EG, Torelli G, Kieny MP.
    PLoS One; 2018 Nov 19; 13(12):e0208028. PubMed ID: 30507951
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G, Coronel J, Pralow A, Marichal-Gallardo P, Wolff M, Rapp E, Karlas A, Sandig V, Genzel Y, Reichl U.
    Vaccine; 2019 Nov 08; 37(47):7019-7028. PubMed ID: 31005427
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Selected problems of manufacturing influenza vaccines].
    Augustynowicz E.
    Przegl Epidemiol; 2010 Nov 08; 64(3):373-80. PubMed ID: 20976949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y, Dietzsch C, Rapp E, Schwarzer J, Reichl U.
    Appl Microbiol Biotechnol; 2010 Sep 08; 88(2):461-75. PubMed ID: 20617311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.